---
title: "Scotiabank Sticks to Its Buy Rating for Hypera S.A. (HYPE3)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284619462.md"
description: "Scotiabank analyst Felipe Ucros has reaffirmed a Buy rating for Hypera S.A. (HYPE3) with a price target of BRL35.00. Ucros, a 3-star analyst with a 5.1% average return and a 64.71% success rate, aligns with the Moderate Buy consensus rating for the stock, which also has an average price target of BRL35.00 according to TipRanks."
datetime: "2026-04-29T16:45:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284619462.md)
  - [en](https://longbridge.com/en/news/284619462.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284619462.md)
---

# Scotiabank Sticks to Its Buy Rating for Hypera S.A. (HYPE3)

Scotiabank analyst Felipe Ucros maintained a Buy rating on Hypera S.A. today and set a price target of BRL35.00.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

According to TipRanks, Ucros is a 3-star analyst with an average return of 5.1% and a 64.71% success rate.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Hypera S.A. with a BRL35.00 average price target.

### Related Stocks

- [HYPMY.US](https://longbridge.com/en/quote/HYPMY.US.md)
- [BRAZ.US](https://longbridge.com/en/quote/BRAZ.US.md)
- [BNS.US](https://longbridge.com/en/quote/BNS.US.md)

## Related News & Research

- [Core Scientific Is Firing on All Cylinders as Analysts Approve Its Expansion Plans](https://longbridge.com/en/news/286808678.md)
- [This Analyst Just Sent Mobileye Stock Down. Here's Why.](https://longbridge.com/en/news/286817003.md)
- [Do Wall Street Analysts Like Equity Residential Stock?](https://longbridge.com/en/news/286806057.md)
- [American Water Works Stock: Analyst Estimates & Ratings](https://longbridge.com/en/news/286850316.md)
- [Q2 EPS Forecast for Avalo Therapeutics Boosted by Analyst](https://longbridge.com/en/news/286903837.md)